Interpretation of 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis: nuclear medicine part
10.3760/cma.j.issn.2095-2848.2018.05.001
- VernacularTitle:2016版美国甲状腺协会《甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》解读:核医学部分
- Author:
Ningyi JIANG
1
Author Information
1. 中山大学孙逸仙纪念医院核医学科
- Keywords:
Thyrotoxicosis;
Hyperthyroidism;
Practice guidelines;
Nuclear medicine;
United States
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2018;38(5):305-310
- CountryChina
- Language:Chinese
-
Abstract:
The new American Thyroid Association (ATA) guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis was published in 2016.Compared to the 100 pieces of evidence-based recommendations in 2011 edition guidelines,the 2016 edition guidelines included 124 pieces of evidence-based recommendations,which made the diagnosis and therapy of thyroid diseases more detailed.As one of the most important treatment for Graves disease (GD),131I therapy was explained more completely in the 2016 edition guidelines,including the indication,the determination of dose,the radiation protection,the reasonable application in children and so on.The purpose of this paper is to interpret the 2016 edition guidelines about the diagnosis and therapy of thyroid diseases in the view of nuclear medicine,focusing on the updated contents.
